Zoomed Image
  • Benadryl Allergy Relief Plus Capsules 12's

Benadryl Allergy Relief Plus Capsules 12's

kes1,080
Add to Cart

In stock 2.00 available!

Description
Benadryl Allergy Relief Plus Decongestant Capsules are a form of medicine that is designed to treat symptoms associated with allergies such as hay fever. The capsules contain 2 active ingredients that help to provide relief, acrivastine and pseudoephedrine. Acrivastine is an antihistamine that works to reduce allergy symptoms and pseudoephedrine is a decongestant that helps to reduce sinus congestion and a blocked nose. Unlike what some may believe, a blocked nose doesn’t happen because of mucus production in the nose, but instead because of inflamed blood vessels. Inflamed blood vessels can happen because of a virus, such as a cold or the flu, or an allergy. When the body comes into contact with a substance that triggers an allergic reaction, the immune system responds by releasing chemicals into the body. This includes a chemical called histamine. Histamine is the cause of many of the symptoms associated with an allergy, included enlarged blood vessels. This is done to reduce blood pressure and help blood flow.
How to use
Posology and method of administration:
Adults and children 12 years and over: Oral. One capsule as necessary, up to three times a day.
Children under 12 years: This product is not currently recommended for use in children under 12 years of age.
The Elderly: This product is not currently recommended for use in the elderly.
Precautions
Contraindications:
This product is contra-indicated in individuals with known hypersensitivity to the product, any of its components or triprolidine. This product is contra-indicated in individuals with known intolerance to the product, any of its components or triprolidine. This product is contra-indicated in patients with severe hypertension or severe coronary artery disease. The concomitant use of a pseudoephedrine-containing product and monoamine oxidase inhibitors can occasionally cause a rise in blood pressure. This product is therefore contra-indicated in patients who are taking, or have taken, monoamine oxidase within the preceding two weeks. The antibacterial agent furazolidone is known to cause a dose-related inhibition of monoamine oxidase. Although there are no reports of hypertensive crises having occurred, it should not be administered concurrently with this product. Renal excretion is the principal route of elimination of acrivastine. Until specific studies have been carried out, this product should not be given to patients with significant renal impairment.